AzPA Pharmacy Flash
Oct. 9, 2013

Support pharmacy in Arizona during American Pharmacists Month
Participate in the First Annual Wear AzPA to Work Day on Oct. 23, and AzPA will treat one participating pharmacy to lunch. Every employee who participates will increase your pharmacy's chance of winning.

Order yours today. More

Health alert: 1st confirmed influenza case of the 2013-2014 season
The Arizona Department of Health Services and the Maricopa County Department of Public Health have confirmed the first influenza case in Arizona for the 2013-2014 influenza season. The patient is a child infected with influenza B as confirmed by PCR at the Arizona State Public Health Laboratory. He had no recent travel out-of-state and was not hospitalized.

We are reminding you of the importance of vaccinating your patients against influenza throughout the flu season. There is ample vaccine supply for the season and all individuals aged 6 months or older should be vaccinated as recommended. For a list of influenza vaccine clinics please go to the website or call 877-764-2670.

For questions regarding the 2013-2014 flu vaccine, you can call your local health agency or the Arizona Immunization Program Office at 602-364-3642 or 602-364-3630. This year's national influenza vaccine recommendations are available online. For more information about flu, please contact your local health department or the Arizona Department of Health Services or log on. More

Flu season may be starting, but agents on furlough can't track it
NBC News
A new flu season may be brewing in the U.S., just as the federal experts who usually monitor the severity and scope of influenza have been idled by a government shutdown. More

Arizona Health-e Connection offers provider incentive program for e-prescribing of controlled substances
Arizona Health-e Connection via AzPA
On April 4, 2012, Gov. Jan Brewer signed into law legislation making the e-prescribing of controlled substances legal. As part of its statewide E-Prescribing Initiative, Arizona Health-e Connection is launching a campaign to increase the awareness and use of e-prescribing of controlled substances.More

Need CE? AzPA Fall Pharmacy Conference: Expanding the Partnership of Pharmacy Care

Date: Saturday, Oct. 26.
This conference offers 6.0 contact hours (0.60 CEUs).More

AzPA Anticoagulation Certificate Program completely revised for 2013 — Register today

Early registration deadline is this Friday, Oct. 11.
Completely revised for 2013, the AzPA Anticoagulation Certificate Program will be presented Oct. 25. More

Residency symposium and workshop: Developing, Expanding and Improving Residency Training Programs in Arizona

Friday, Oct. 18
Learn how to establish or expand a residency at your practice site.

FDA issues final mobile medical app guidance
By Pamela Lewis Dolan
The U.S. Food and Drug Administration recently issued its final guidance on mobile health apps, ending a two-year wait for developers. The FDA, which issued a draft guidance in July 2011, said it intends to exercise its enforcement discretion and not regulate apps except for those that present a risk to patients if they do not work as intended. While some industry groups were happy the FDA made good on its promise to release the document before the end of fiscal year 2013, others say the FDA should have waited a little longer.More

Reducing the guesswork in drug dosing
Medical News Today
The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say. The scientists found two genetic variants that alter the activity level of an enzyme responsible for processing drugs, ranging from the painkiller codeine to the breast cancer drug tamoxifen. More

Patients happier with brick-and-mortar pharmacies
Pharmacy Times
Despite a slight uptick in customer satisfaction with mail-order pharmacies, a new report from J.D. Power suggests that customers are still significantly more pleased with their experiences at brick-and-mortar pharmacy locations than those with mail-order pharmacies. More

California provider status bill becomes law
Gov. Jerry Brown of California signed the state's pharmacist provider status bill into law Oct. 1, according to the governor's website. Effective Jan. 1, the new law declares pharmacists are healthcare providers. It gives new authorities to all licensed pharmacists, establishes an Advanced Practice Pharmacist recognition, gives new authorities to APPs and specifies requirements for pharmacists seeking recognition as APPs. It does not address payment.More

'Cruise ship virus' vaccine a 1st-class idea?
HealthDay News
The dreaded "cruise ship virus" could sink into history someday if a promising vaccine trial pans out. Researchers report that an early test of an experimental vaccine for norovirus — the cause of a stomach sickness that fells scores of cruise ship passengers and nursing home residents, among others — reduced symptoms of vomiting and diarrhea by 52 percent.More

Dual antiplatelet therapy and ASA allergy: What do you do?
How do you manage a patient with acute coronary syndrome who requires dual antiplatelet therapy but has an aspirin allergy? Aspirin sensitivity poses a significant clinical dilemma, as the safety and efficacy of oral antiplatelet combinations that exclude aspirin have not been established. Aspirin desensitization is a possible approach, but it may not always be feasible because of the urgent nature of cardiac intervention or the need for close observation in a setting equipped with resuscitative equipment.More

Pharmacist interventions improve outcomes, reduce costs for home infusion therapy patients
Medical News Today
Outcomes improve and there can be significant cost savings when infusion pharmacists monitor patients receiving home-based infusion and intervene when dose adjustments are necessary, according to a Walgreen outcomes analysis study being presented at IDWeek 2013 in San Francisco.More

Reducing the guesswork in drug dosing
Medical News Today
The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say. More

Antibiotics recommended for all toddlers with ear infections
Pharmacy Times
In a research letter, researchers recommend that all children aged 6 months to 2 years diagnosed with acute otitis media be treated with antibiotics. More

Rapid opioid detox method linked to hospitalizations, deaths
Pharmacy Practice News
Drug rehabilitation clinics should no longer administer a controversial opioid detoxification method, government health officials have said. More

Vitamin D for all to prevent MS?
Whether enough evidence supports universal supplementation with vitamin D to reduce the risk for multiple sclerosis was the subject of debate at one of the first sessions of the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.More

Brintellix approved for major depressive disorder
HealthDay News
Brintellix has been approved by the FDA to treat adults with major depressive disorder, often referred to as depression. In seven clinical studies, Brintellix proved effective in treating depression and in preventing future episodes, the FDA said in a news release. The most common side effects observed included nausea, constipation and vomiting.More

Lipid injectable emulsion approved by FDA
American Society of Health-System Pharmacists
The FDA recently approved the marketing of a 20 percent lipid injectable emulsion, Clinolipid, for use in meeting the nutritional needs of adults when oral or other enteral nutrition is not possible or sufficient. Agency officials said the marketing application for Clinolipid underwent "priority review" to help alleviate the ongoing shortage of injectable lipid emulsion products.More

Death row inmates sue Texas for sourcing execution drug from compounding pharmacy
Death row inmates are suing the state of Texas for obtaining a killing drug from a compounding pharmacy after its previous supply of pentobarbital expired in September. The lawsuit says the drug carries "a high risk of excruciating pain."More